The efficacy and feasibility of adopting intravenous chemotherapy and oral S-1 as a sequential therapy for postoperative gastric cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The efficacy and feasibility of adopting intravenous chemotherapy and oral S-1 as a sequential therapy for postoperative gastric cancer patients

Published:2019-11 Issue:44 Volume:98 Page:e17605
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Yan Long,Liu Hongbin,Li Hongtao,Han Xiaopeng,Cao Tingbao,Wang Chaoyang,Li Gaitian

Funder

Gansu provincial science and Technology Department Grants

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference20 articles.

1. Latest developments and emerging treatment options in the management of stomach cancer;Delaunoit;Cancer Manag Res,2011

2. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data;Wagner;J Clin Oncol,2006

3. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trail;Noh;Lancet Oncol,2014

4. Global chemotherapy development for gastric cancer;Harada;Gastric Cancer,2017

5. A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma;Blum;Future Oncol,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP